Stratasys Direct Production Growth
Stratasys Direct delivered >10% sequential growth and 23% organic year-over-year growth (after divestments) versus Q1 2025, shipping over 100,000 production parts annually and showing strong production-part demand across industries (top 3 parts customers were U.S. drone-related firms).
Defense & Aerospace Momentum
Selected for the U.S. Department of War JAMA IV pilot parts program (multimillion-dollar initiative), cited as program of record for USAF and NAVAIR, deployed thousands of systems across aerospace/defense, parts (e.g., C-17 microvanes) estimated to save $14M annually in fuel, and hundreds of components with Stratasys materials flew on Artemis II; U.S. defense additive budget cited as having surged 83% for FY2026.
Regulatory Win in Dental (TrueDent)
TrueDent Resin received CE Class IIa certification (first polychromatic monolithic 3D printed denture solution), expanding indications to long-term intraoral removables and crowns/bridges in Europe—addressing a segment projected at $2.45B in Europe by 2028 (U.S. removables opportunity cited ~ $5B).
Product, Materials and Software Enhancements
New materials and platform updates: ULTEM 1010 filament available for F3300 (aerospace-grade, low CTE), TUF1 material expanded to J3/J5 series, and measurement-based warped adaptive modeling integrated into GrabCAD Print Pro (reducing iteration and improving production accuracy on DLP platforms).
Financial Stability & Liquidity
Maintained adjusted EBITDA profitability ($2.0M) and generated positive operating cash flow ($2.4M) in Q1; ended quarter with $237.8M in cash, cash equivalents and short-term deposits and a debt-free balance sheet, providing flexibility for organic and inorganic investments.
Recurring Revenue Resilience
Recurring streams (consumables and customer support/services) provided stability: service revenue (including Stratasys Direct) was $43.9M (up vs $42.2M prior year) and consumables remained a meaningful base ($60.0M), with consumables and services both growing slightly on a sequential basis.
Full-Year Guidance Reiterated
Company reiterated 2026 revenue guidance of $565M–$575M and expects consumables revenue to increase versus 2025, with management expecting sequential revenue growth through the year and H2 momentum (defense-driven) supporting the plan.